ALL >> Business >> View Article
More Than 35 Industry Players Claim To Offer Services For The Identification, Characterization And D
Drug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has emerged as one of the recent trends in the overall pharmaceutical domain.
To order this 180+ page report, which features 90+ figures and 85+ tables, please visit this link
The USD 1.5 billion (by 2030) financial opportunity within the peptides and macrocycles drug discovery service and platform providers market has been analyzed across the following segments:
Type of peptides
Synthetic peptides
Biologic and recombinant peptides
Type of discovery steps
Target identification and validation
Hit identification
Lead generation
Lead optimization
Therapeutic Area
Oncological disorders
Metabolic disorders
Cardiovascular disorders
Infectious diseases
Urological disorders
Endocrine disorders
...
... CNS disorders
Other diseases
Company Size
Small companies
Mid-sized companies
Large and very large companies
Key geographical regions
Europe
North America
Asia-Pacific and the Rest of the World
The report features inputs from eminent industry stakeholders, according to whom peptide and macrocycles drug discovery outsourcing market is continuously pacing up. The report includes detailed transcripts of discussions held with the following experts:
Mark I Peterson (CEO, Cyclenium Pharma)
Jan Hoflack (Chief Scientific Officer, Head of Biotech Business Unit, Oncodesign)
The research covers profiles of key players that offer peptides and macrocyclic drugs discovery platforms and services, featuring an overview of the company, its service portfolio / technology platform, and an informed future outlook.
GenScript
JPT Peptide Technologies
CPC Scientific
IRBM
Creative Peptides
Pepscan
Interprotein
RA Pharmaceuticals
Pepticom
PeptiDream
Creative Biolabs
MeSCue-Janusys
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape of Service Providers
5. Benchmark Analysis
6. Market Landscape of Platform Providers
7. Company Profiles
8. Partnerships
9. Market Forecast and Opportunity Analysis
10. SWOT Analysis
11. Conclusion
12. Executive Insights
13. Appendix 1: List of Companies and Organizations
14. Appendix 1: Tabulated Data
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Add Comment
Business Articles
1. Lucintel Forecasts The Global Crude Heater Market Is Expected To Grow With A Cagr Of 4.5% From 2024 To 2030Author: Lucintel LLC
2. How To Measure The Success Of Your Rpo Partnership
Author: VanatorRPO
3. Lucintel Forecasts The Global Cough Remedy Market To Reach $1 Billion By 2030
Author: Lucintel LLC
4. Are There Different Types Of Esd Tables Available?
Author: Jagadeesan
5. How To Extend The Lifespan Of Your Hydraulic Industrial Lift
Author: Jagadeesan
6. How Best Quality Skin Hydration Mask Work For Your Skin?
Author: Xtaz Mask
7. Mayank Domestic And International Movers | Call: @8792441400
Author: mayanksharma
8. Channel Partner Intelligence: The Power Of Collaborations To Unleash Growth
Author: Netscribes
9. How Customer Intelligence Helps Design Intelligent Business Practices
Author: Netscribes
10. The Importance And Evolution Of School Uniforms: A Comprehensive Guide
Author: abushaikh7261
11. Iso 17020 Certification Conformity Assessment - Comparison Of Iso 17020 And Iso 17025 Standards
Author: Sahin Alam
12. Dialyzer Market Size, Trends, Analysis, Demand, Outlook And Forecast By 2030
Author: pranju
13. How Can Ansoff Matrix Be Used For Developing Successful Business Strategies?
Author: Expandus Business Coaching
14. Deep Cleaning Service In Gurgaon
Author: Balaji Cleaning Agency
15. Lucintel Forecasts The Global Catheter Market To Reach $42 Billion By 2030
Author: Lucintel LLC